Amazing stability of phosphate-quaternary amine interactions

Journal of Proteome Research

Volumn 7, Issue 8, 2008, Pages 3423-3427

  Woods, Amina S ^a   Moyer, Susan C ^b   Jackson, Shelley N ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b AGILENT TECHNOLOGIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; DECAMETHONIUM; GUANIDINE; HEXAMETHONIUM; PHOSPHATE; SUXAMETHONIUM; NEUROMUSCULAR DEPOLARIZING AGENT; NICOTINIC RECEPTOR BLOCKING AGENT; PHOSPHOPEPTIDE;

ARTICLE; CHEMICAL INTERACTION; DRUG FORMULATION; DRUG STABILITY; ELECTROSPRAY MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PHOSPHORYLATION; PRIORITY JOURNAL; CHEMISTRY;

ACETYLCHOLINE; DECAMETHONIUM COMPOUNDS; HEXAMETHONIUM; NEUROMUSCULAR DEPOLARIZING AGENTS; NICOTINIC ANTAGONISTS; PHOSPHOPEPTIDES; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SUCCINYLCHOLINE;

EID: 53049087282     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr8001595     Document Type: Article

References (15)

1. Woods, A. S.; Fuhrer, K.; Gonin, M.; Egan, T.; Ugarov, M.; Gillig, K. J.; Schultz, J. A. AngiotensinII/Acetylcholine Non-Covalent Complexes Analyzed with MALDI-Ion Mobility-TOFMS.J. Biomol. Tech. 2003, 14, 1-8.
2. Woods, A. S. The Mighty Arginine, the Stable Quaternary Amines, the Powerful Aromatics and the Aggressive Phosphate: Their Role in the Noncovalent Minuet.J. Proteome Res. 2004, 3, 478-484.
3. Woods, A. S.; Moyer, S. C; Wang, H. Y.; Wise, R. A. Interaction of Chlorisondamine with the Neuronal Nicotinic Acetylcholine Receptor. J. of Proteome Research 2003, 2, 207-212.
4. Wang, H. Y. J.; Taggi, A. E.; Meinwald, J.; WiseR.A.; Woods, A. S. A Study of the Interaction of Chlorisondamine and Chlorisondamine analogs with An Epitope of the α Neuronal Acetylcholine Nicotinic Receptor Subunit. J. Proteome Res. 2005, 4, 532-539.
5. Johnson, L. N.; Lewis, R. J. Structural basis for control by phosphorylation. Chem. Rev. 2001, 101, 2209-2242.
6. The Physician Desk Reference (PDR), 62nd ed.; Thomson: Montvale, NJ, 2008.
7. Hardman, J. G.; Limbird, L. E.; Gilman, A. G. Goodman & Gilman's The Pharmacological Basis of Therapeutics, 10th ed.; McGraw-Hill: New York, 2001.
8. Moyer, S. C.; Cotter, R. J.; Woods, A. S. Fragmentation of phos- phopeptides by atmospheric pressure MALDI and ESI/ion trap mass spectrometry.J. Am. Soc. Mass Spectrom. 2002, 13, 274-283.
9. Moyer, S. C; VonSeggern, C. E.; Cotter, R. J. Fragmentation of phosphotyrosine containing peptides by atmospheric pressure MALDI/ion trap mass spectrometry. J. Am. Soc. Mass Spectrom. 2003, 14, 581-592.
10. Woods, A. S.; Ferre, S. The Amazing Stability of the Arginine- Phosphate Electrostatic Interaction.J. Proteome Res. 2005, 4, 1397- 1402.
11. Jackson, S. N.; Wang, H. Y. J.; Yergey, A.; Woods, A. S. Phosphate stabilization of intermolecular interactions.J. Proteome Res. 2006, 5, 122-126.
12. Jackson, S. N.; Wang, H. Y. J.; Woods, A. S. A study of the Fragmentation Patterns of the Phosphate-Arginine Noncovalent Bond. J. Proteome Res. 2005, 4, 2360-2363.
13. Woods, A. S.; Ciruela, F.; Fuxe, K.; Agnati, L. F.; Lluis, C. zprintx>.; Franco, R.; Ferré, S. The role of electrostatic interaction in receptor- receptor heteromerization. J. Mol. Neurosci. 2005, 6, 125-132.
14. Schug, K. A.; Lindner, W. Noncovalent binding between guanidinium and anionic groups: focus on biological- and synthetic- based arginine/guanidinium interactions with phosph[on]ate and sulf[on]ate residues. Chem. Rev. 2005, 105, 67-114.
15. Alves, S.; Fournier, I.; Alfonso, C; Wind, F.; Tabet, J. Gas-phase ionization/desolvation processes and their effect on protein charge state distribution under matrix-assisted laser desorption/ionization conditions. Eur. J. Mass Spectrom. 2006, 12, 369-383.